Literature DB >> 6281306

Rapid typing of herpes simplex virus based on immunological specificity of viral thymidine kinase and typing according to sensitivity to iododeoxyuridine.

J S Gronowitz, C F Källander, S Jeansson, J Wallin.   

Abstract

We describe two methods for typing of herpes simplex virus (HSV). One procedure is based on the finding that the multiplication of HSV type 1 strains in primary rabbit kidney cells is inhibited by 2 x 10(-5) M iododeoxyuridine, whereas growth of HSV type 2 strains is considerably less affected. Forty-nine different HSV isolates were typed according to this method. For all isolates except two the results were found to be in agreement with results obtained by another typing procedure, the counterimmunoelectroosmophoretic method (S. Jeansson, Appl. Microbiol. 24:96-100, 1972). One HSV type 1 isolate behaved as a type 2 strain and was found to be a deoxythymidine kinase-negative mutant strain. The other deviant strain exhibited an intermediate iododeoxyuridine sensitivity, thus being impossible to type with this method. Another, faster typing procedure which is based on the immunological difference between HSV type 1 and 2 deoxythymidine kinase is also presented. This assay, in combination with the conventional methods for isolation, enables the detection of deoxythymidine kinase-negative therapy-resistant HSV strains. Finally, we report the detection and typing of HSV deoxythymidine kinase present in vesicle fluids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281306      PMCID: PMC272101          DOI: 10.1128/jcm.15.3.366-371.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Differentiation between herpes simplex virus type 1 and type 2 strains by immunoelectroosmophoresis.

Authors:  S Jeansson
Journal:  Appl Microbiol       Date:  1972-07

2.  Serological properties of thymidine kinase produced in cells infected with type 1 or type 2 herpes virus.

Authors:  M E Thouless
Journal:  J Gen Virol       Date:  1972-12       Impact factor: 3.891

3.  "Treatment-resistance" to idoxuridine in herpetic keratitis.

Authors:  V R Coleman; E Tsu; E Jawetz
Journal:  Proc Soc Exp Biol Med       Date:  1968-12

Review 4.  Problems in virus chemotherapy.

Authors:  H E Kaufman
Journal:  Prog Med Virol       Date:  1965

Review 5.  Viral-associated and induced enzymes.

Authors:  S Kit
Journal:  Pharmacol Ther B       Date:  1979

6.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.

Authors:  E De Clercq; J Descamps; G Verhelst; R T Walker; A S Jones; P F Torrence; D Shugar
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

7.  Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase.

Authors:  B Eriksson; A Larsson; E Helgstrand; N G Johansson; B Oberg
Journal:  Biochim Biophys Acta       Date:  1980-03-28

8.  Sensitivity of Types 1 and 2 Herpes Simplex Virus to 5-Iodo-2'-Deoxyuridine and 9-beta-d-Arabinofuranosyladenine.

Authors:  D A Person; P J Sheridan; E C Herrmann
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

9.  Occurrence of antibodies against herpes simplex virus thymidine kinase in human sera.

Authors:  J S Gronowitz; C F Källander
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

10.  Optimized assay for thymidine kinase and its application to the detection of antibodies against herpes simplex virus type 1- and 2-induced thymidine kinase.

Authors:  J S Gronowitz; C F Källander
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

View more
  5 in total

Review 1.  Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications.

Authors:  M Hallek; L Wanders; S Strohmeyer; B Emmerich
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

2.  Characterization of an Epstein-Barr virus-induced thymidine kinase.

Authors:  M de Turenne-Tessier; T Ooka; G de The; J Daillie
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strains.

Authors:  J Harmenberg; V A Sundqvist; H Gadler; B Levén; G Brännström; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

4.  Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells. Brief report.

Authors:  J Harmenberg; C F Källander; J S Gronowitz
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

5.  Rapid diagnosis of varicella-zoster virus infection by detection of viral deoxythymidine kinase in serum and vesicle fluid.

Authors:  C F Källander; J S Gronowitz; E Olding-Stenkvist
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.